[Neopergonal treatment in male hypogonadotropic hypogonadism (author's transl)].
Male hypogonadotropic hypogonadism is a rare disease but a caracteristic one of currently isolated gonadotropin deficiency. 15 subjects have been treated during 6 to 52 monthes with Neopergonal (225 UI a week) + H.C.G. (15 00 IU a week). We observed spermatogenesis onset in 11 patients, sufficient 9 of them, poor in 2 others.
D000293:Adolescent; D000328:Adult; D006063:Chorionic Gonadotropin / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006062:Gonadotropins / Q000172:deficiency*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D008596:Menotropins / Q000494:pharmacology / Q000627:therapeutic use*; D013091:Spermatogenesis / Q000187:drug effects
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D008596:Menotropins
Place du Néopergonal dans le traitment des impubérismes hypogonadotrophiques masculins.